Back to search

Georgia Institute of Technology

Hybrid Lipid Nanocapsules: A Robust Nanoplatform for the Co-delivery of Resiquimod and mRNA

Abstract

dc:description.abstract

The ever-progressing field of cancer immunotherapy has sparked interest in development of unique drug platforms. This thesis explores the use of hybrid lipid nanocapsule as a co-delivery platform for mRNA and resiquimod, a toll-like receptor 7/8 agonist. The co-formulation aimed to synergistically combine antigen expression through mRNA transfection with the innate immune stimulation by resiquimod. The formulation of hLNCs with engineered presented optimal characteristics for targeting tumors as well as excellent encapsulation efficiency of resiquimod. This co-delivery of resiquimod with mRNA may enhance immune activation and accurate delivery to target solid-state tumors.

Degree

thesis:*
Level thesis:degree_level
Masters
Department dc:contributor.department
Chemistry and Biochemistry
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Moss, Avery Elizabeth
Advisor dc:contributor.advisor
  • Cicerone, Marcus
Committee members dc:contributor.committeemember
  • Finn, M.G
  • Oyelere, Yomi

Subjects

dc:subject × 1

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/78660

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Moss, Avery Elizabeth. Hybrid Lipid Nanocapsules: A Robust Nanoplatform for the Co-delivery of Resiquimod and mRNA. Masters thesis, Georgia Institute of Technology, 2025. https://hdl.handle.net/1853/78660